La Jolla, CA, United States of America

Daniel K Nomura

This inventor holds 2 USPTO granted patents. Top assignee: Scripps Research Institute. Active years: 2014-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel K Nomura. Retrieved from https://idiyas.com/inventor/daniel-k-nomura-ednjs62v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • La Jolla, CA (US) (2014)
  • San Diego, CA (US) (2016)

Company Filing History:


Years Active: 2014-2016

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Daniel K. Nomura

Introduction

Daniel K. Nomura is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific enzymes related to various health conditions. With a total of 2 patents, his work focuses on addressing critical medical challenges, including cancer and metabolic disorders.

Latest Patents

Nomura's latest patents include groundbreaking inventions aimed at combating cancer. One of his notable patents is for anti-cancer serine hydrolase inhibitory carbamates. This invention targets serine hydrolases, which are implicated in several malconditions such as cancer and central nervous system disorders. The compounds identified through his research can be used for the treatment of conditions associated with the serine hydrolase KIAA1363, also known as AADACL1. His exemplary compound has shown effectiveness in inhibiting prostate cancer pathogenesis.

Another significant patent involves methods and compositions related to targeting monoacylglycerol lipase (MAGL). This invention provides selective inhibitors of MAGL, which can stimulate endocannabinoid signaling in vivo. The methods developed by Nomura also offer potential treatments for cancer by inhibiting tumor growth through MAGL-specific inhibitors.

Career Highlights

Daniel K. Nomura is affiliated with the Scripps Research Institute, where he conducts his research and development. His work has garnered attention for its innovative approach to tackling complex health issues through targeted biochemical strategies.

Collaborations

Nomura has collaborated with notable scientists in his field, including Benjamin F. Cravatt and Jae Won Chang. These collaborations have further enhanced the impact of his research and contributed to the advancement of medicinal chemistry.

Conclusion

Daniel K. Nomura's innovative contributions to the field of medicinal chemistry highlight his commitment to addressing significant health challenges. His patents reflect a deep understanding of biochemical processes and a dedication to developing effective treatments for serious conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…